Target intelligence / Profile preview

Ribosomal protein L19 pseudogene 16 (RPL19P16)

Target
RPL19P16
Molecular classification
Other (Pseudogene)
01

Overview

RPL19P16 (Ribosomal protein L19 pseudogene 16) is a processed pseudogene identified in the human genome and is related by sequence to RPL19, which encodes a component of the 60S ribosomal subunit[1][3][5]. Pseudogenes such as RPL19P16 do not encode functional proteins: they arise from retrotransposition or duplication events of functional ribosomal protein genes and typically do not retain the regulatory elements or open reading frames necessary for gene expression[6]. As a result, RPL19P16 is not considered a therapeutic target, does not participate in protein synthesis, and has no known role in disease, biological function, or drug interaction. There are numerous ribosomal pseudogenes in the human genome, but their biological impact is negligible except in rare cases where they might influence gene regulation by other means[6]. *Note: If you seek information about the functional ribosomal protein, refer to "Ribosomal protein L19" (RPL19), not this pseudogene.*

Other names
RPL19_5_1105[5]

Beyond the preview

Go deeper on Ribosomal protein L19 pseudogene 16 (RPL19P16).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L19 pseudogene 16 (RPL19P16).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call